Sanofi Group Head of Global Medical Affair Sutimlimab in Cambridge, Massachusetts
This person will play a key leadership role within the RBD franchise and will lead a team of global medical professionals dedicated to supporting various products within the Complement Disorders Therapeutic Area (TA). He/she will be in charge of developing and ensuring the execution of the global medical strategy in alignment with the global brand strategy for each of the projects in this TA (CAD, ITP, Sickle Cell, and Beta Thalassemia). This person will be expected to successfully collaborate with alliance partners where they exist.
The position requires excellence in strategic planning and operational execution; this person will provide leadership, help build strategic plans, supervise the development, implementation and execution of global medical activities, and interface with the regional/affiliate medical leads. In addition, this person is expected to have the ability to work effectively in a highly matrixed environment and demonstrate outstanding interpersonal skills. A strong commitment to achieving corporate objectives while maintaining the highest ethical, regulatory and scientific standards is required.
The GMH leads the strategy creation and implementation and ensures timely execution of all assigned complement disorders portfolio’s medical projects. The GMH develops and communicates a vision for each of the portfolio products. In partnership with the Complement Brand Lead, the GMH is responsible for defining the assigned products’ medical plans, portfolio strategy and prioritization, integrated project strategies, and risk management across life cycle. The GMH is responsible for providing medical leadership at company forums, supporting scientific communication and patient advocacy, optimizing global KOL relationships, supporting business development and external innovation efforts to identify and evaluate new pipeline molecules, and advising the Global Medical Head RBD on the medical strategy of the complement disorders portfolio.
The GMH is responsible for collaborating in a matrix environment with leaders from other divisions, enabling functions to align strategies, processes and resources, and identifying areas of organizational improvement. The GMH represents Sanofi Medical internally and externally for his/her product portfolio.
Key Individual Accountabilities:
Responsible for the medical strategy and execution of the complement disorder portfolio.
Collaborates with R&D, in executing and delivering the early development pipeline.
Builds strong interactions with key stakeholders in a matrix organization including New Product Planning, Commercial, Scientific Communications, Clinical Science & Operations, Regulatory, Safety and Pharmacovigilance, Value & Access, Clinical Development, Strategy & Business Development, to ensure shared / integrated strategic vision for the pipeline portfolio.
Establishes global medical unit goals and prioritizes activities in alignment with the overall global brand strategy for the complement disorders products.
Leads the complement disorders therapeutic area Medical Unit.
Leads/Manages the Global Medical Directors, provides coaching to team members, and resolves issues escalated from them.
Influences a broad range of stakeholders, collaborates in a matrix environment with leaders from other divisions enabling functions to align strategies, processes, and resources, and identifies areas of organizational improvement.
Prioritizes activity and resource allocation across the various complement disorders therapeutic area portfolio.
Provides leadership to the global complement disorders medical team
Oversees the execution of life-cycle evidence generation, ensures the appropriate processes are in place for review, approval, management and support of high-quality studies (CSS, IIS, HEVA, EDA, Biostat etc.).
Leads the overall medical data dissemination/publication strategy and collaborates with the Scientific Communication group to ensure scientifically sound, balanced, accurate and timely disclosure of SGZ data in the complement disorders space.
Oversees the creation and implementation of internal and external training and education activities. Collaborates with the regional medical heads in US, EU, JAPAK, and China & emerging markets when necessary.
Works closely and compliantly with New Product Planning/Global Brand Lead to ensure aligned strategies and coordinated plans.
Leads the complement disorders global KOL relationship management.
Collaborates cross-functionally with other groups to support the complement disorders products and provide clear medical guidance.
Participates in relevant SGZ Product Teams to provide expertise and ensure strategic alignment of medical affairs with clinical development and commercial activities.
Represents SGZ global medical affairs at medical meetings, advisory boards, meetings at key institutions, and in interactions with global KOLs.
Oversees the management of the budget for his/her TA.
Accountable for the financial management and reporting requirements for medical affairs complement disorders TA.
Travels regularly (both internationally and within the US) as necessary.
MD, PhD, or Pharm D. MD preferred, Board Certification in Hematology or Pediatric Hematology ideal.
Experience in Medical Affairs and in Hematology is a plus.
In-depth understanding of and proven success in how to conceptualize, design, and conduct complex, global clinical trials.
Excellent communication skills both written and oral, including strong presentation skills.
Ability to manage competing priorities and projects, as well as expectations.
Commitment to a culture that operates with high ethical standards and strives to exceed all goals and objectives.
Demonstrated ability to inspire confidence while leading a team and working effectively in a matrix environment.
Comfortable operating in a consensus building role, making specific recommendations and decisions, and driving implementation.
Ability to understand and effectively communicate scientific data results, and information to internal and external stakeholders.
Excellent communication skills with the ability to build strong working relationships with cross functional stakeholders, as well as to negotiate with and to influence across different cultures.
Evidence of strong interpersonal skills and high emotional intelligence.
Demonstrated strength in analytical skills, and in managing through ambiguity.
Excellence in solving problems, and exhibiting good judgment.
A team player; able to collaborate successfully with both internal and external colleagues.
Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
At Sanofi diversity and inclusion is foundational to how we operate and embedded in our Core Values. We recognize to truly tap into the richness diversity brings we must lead with inclusion and have a workplace where those differences can thrive and be leveraged to empower the lives of our colleagues, patients and customers. We respect and celebrate the diversity of our people, their backgrounds and experiences and provide equal opportunity for all.